Serious Event

Serious Event

Serious Adverse Events (SAEs) are adverse events that result in death, are life-threatening, require or prolong hospitalization, cause persistent or significant disability/incapacity, or are congenital anomalies/birth defects. Each serious event is categorized by term, organ system, assessment type, and source vocabulary to provide standardized reporting across clinical trials.

Serious Event path is as follows:

Study -> Results Section -> Adverse Events Module -> Serious Event

Study -> Results Section -> Adverse Events Module -> Serious Event -> Serious Event Stats

Serious Event


Ignite Creation Date: 2025-12-25 @ 1:37 AM
Ignite Modification Date: 2025-12-25 @ 11:53 PM
NCT ID: NCT00299494
Term: Cancer pain
Organ System: Neoplasms benign, malignant and unspecified (incl cysts and polyps)
Assessment Type: NON_SYSTEMATIC_ASSESSMENT
Source Vocabulary: MedDRA version 17.0
Notes: None
Study: NCT00299494
Study Brief: Study Evaluating Inotuzumab Ozogamicin [CMC-544] Administered In Combination With Rituximab In Subjects With Non-Hodgkin's Lymphoma (NHL)
Serious Event Stats (If Any):

Serious Event Stats

Group ID # Events # Affected # At Risk View
EG000 None 1 5 View
EG001 None 0 3 View
EG002 None 0 7 View
EG003 None 0 34 View
EG004 None 0 40 View
EG005 None 0 30 View